Key Considerations KLOW is not FDA-approved and should only be used in research settings
Severe obesity in children and adolescents: Identification, associated health risks, and treatment approaches: A scientific statement from the American Heart Association
North American Society for Pediatric Gastroenterology, hepatology, and nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome
Despite the retrospective nature of his groups study, the efficacy observed in a large population, as well as the favorable safety profile of GLP-1 agents vs
The second observational study looked at the health records of more than 12,000 people and found that GLP-1s were associated with a lower risk of tumour spread in lung, breast, colorectal and liver cancer by just under 40% to 50% (depending on type), compared with older drugs called gliptins